All In MedTech

FDA Clearance Tracker · P960009-S293

Activa Deep Brain Stimulation Therapy System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 11, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 11, 2018

Approved

Time to decision

191 days

Received Sep 1, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P960009-S293
Device name
Activa Deep Brain Stimulation Therapy System
Applicant location
Minneapolis, MN
Received
Sep 1, 2017
Decided
Mar 11, 2018
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P960009

Device type

Device class
Class III

Every decision under product code MHY

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at Medronic Puerto Rico Operations Company, Villalba, Rd. 149, Km 56.3 , Cal box 6001, Villaba, Puerto Rico for manufacture of the 1x4 Pocket Adaptors (models 74001 and 64001) and 2x4 Pocket Adaptors (models 74002 and 64002).

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.